US biotech firm wants to test its pneumonia treatment in COVID-19 patients

BioAegis of New Jersey is developing a drug using gelsolin, a protein that helps to clear away inflammation from pneumonia, which is responsible for the deaths of coronavirus patients.

from Health News | Mail Online https://ift.tt/33RQANN